Literature DB >> 8709257

Peripheral blood mononuclear cells from sheep infected with a variant of bovine leukemia virus synthesize envelope glycoproteins but fail to induce syncytia in culture.

E R Johnston1, M A Powers, L C Kidd, K Radke.   

Abstract

Peripheral blood mononuclear cells (PBMCs) infected with the oncogenic retrovirus bovine leukemia virus (BLV) produce virus when cultured briefly. BLV can be transmitted in cocultures to adherent susceptible cells, which become infected, express viral proteins, and fuse into multinucleated syncytia several days later. PBMCs from 3 of 10 BLV-infected sheep displayed a lifelong deficiency in induction of syncytium formation among indicator cells in culture, although large numbers of PBMCs synthesized viral transcripts or capsid protein. Since the infected, syncytium-deficient PBMCs were > or = 97% B cells, the deficiency could not be attributed to altered host cell tropism. The syncytium-deficient phenotype was recapitulated in newly infected sheep, demonstrating that this property is regulated by the viral genotype. The alteration in the BLV genome delayed but did not prohibit the establishment of BLV infection in vivo. Envelope glycoproteins were synthesized in syncytium-deficient PBMCs, translocated to the cell surface, and incorporated into virions. However, monoclonal antibodies specific for the BLV surface glycoprotein did not stain fixed PBMCs of the syncytium-deficient phenotype. Moreover, an animal with syncytium-deficient PBMCs had lower titers of neutralizing antibodies throughout the first 5 years of infection than an animal with similar numbers of infected PBMCs of the syncytium-inducing phenotype. The syncytium-deficient variant productively infected indicator cells at greatly reduced efficiency, showing that the alteration affects an early step in viral entry or replication. These results suggest that the alteration maps in the env gene or in a gene whose product affects the maturation or conformation, and consequently the function, of the envelope protein complex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709257      PMCID: PMC190655          DOI: 10.1128/JVI.70.9.6296-6303.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Direct syncytial assay for the quantitation of bovine leukemia virus.

Authors:  C V Benton; A E Soria; R V Gilden
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

2.  Topographical analysis by monoclonal antibodies of BLV-gp51 epitopes involved in viral functions.

Authors:  C Bruck; D Portetelle; A Burny; J Zavada
Journal:  Virology       Date:  1982-10-30       Impact factor: 3.616

3.  Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species.

Authors:  J Deschamps; R Kettmann; A Burny
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

4.  Use of a continuous feline cell line for virologic and serologic investigations of bovine leukemia virus infections.

Authors:  M J Van der Maaten; J M Miller
Journal:  Am J Vet Res       Date:  1980-11       Impact factor: 1.156

5.  Lymphocyte activators elicit bovine leukemia virus expression differently as asymptomatic infection progresses.

Authors:  L C Kidd; K Radke
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

6.  Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51.

Authors:  C Bruck; S Mathot; D Portetelle; C Berte; J D Franssen; P Herion; A Burny
Journal:  Virology       Date:  1982-10-30       Impact factor: 3.616

7.  Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses.

Authors:  P J Fischinger; C S Blevins; S Nomura
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

8.  Early syncytium formation by bovine leukemia virus.

Authors:  D C Graves; L V Jones
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

9.  Use of a feline cell line in the syncytia infectivity assay for the detection of bovine leukemia virus infection in cattle.

Authors:  J F Ferrer; C Cabradilla; P Gupta
Journal:  Am J Vet Res       Date:  1981-01       Impact factor: 1.156

10.  The envelope proteins of bovine leukemia virus: purification and sequence analysis.

Authors:  A M Schultz; T D Copeland; S Oroszlan
Journal:  Virology       Date:  1984-06       Impact factor: 3.616

View more
  8 in total

1.  Dissemination of bovine leukemia virus-infected cells from a newly infected sheep lymph node.

Authors:  B E Fulton; M Portella; K Radke
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Prostaglandin E2-Induced Immune Exhaustion and Enhancement of Antiviral Effects by Anti-PD-L1 Antibody Combined with COX-2 Inhibitor in Bovine Leukemia Virus Infection.

Authors:  Yamato Sajiki; Satoru Konnai; Tomohiro Okagawa; Asami Nishimori; Naoya Maekawa; Shinya Goto; Kei Watari; Erina Minato; Atsushi Kobayashi; Junko Kohara; Shinji Yamada; Mika K Kaneko; Yukinari Kato; Hirofumi Takahashi; Nobuhiro Terasaki; Akira Takeda; Keiichi Yamamoto; Mikihiro Toda; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal:  J Immunol       Date:  2019-07-31       Impact factor: 5.422

3.  Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep.

Authors:  N Chevallier; M Berthelemy; D Le Rhun; V Lainé; D Levy; I Schwartz-Cornil
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  The SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions.

Authors:  E R Johnston; K Radke
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.

Authors:  Elizabeth R Johnston; Lorraine M Albritton; Kathryn Radke
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  A mutant form of the tax protein of bovine leukemia virus (BLV), with enhanced transactivation activity, increases expression and propagation of BLV in vitro but not in vivo.

Authors:  Shigeru Tajima; Masahiko Takahashi; Shin-Nosuke Takeshima; Satoru Konnai; Shan Ai Yin; Shinobu Watarai; Yoshimasa Tanaka; Misao Onuma; Kosuke Okada; Yoko Aida
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 7.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

Review 8.  Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus.

Authors:  Yoko Aida; Hironobu Murakami; Masahiko Takahashi; Shin-Nosuke Takeshima
Journal:  Front Microbiol       Date:  2013-11-08       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.